Standard BioTools focuses on protein biomarkers and has carried out thousands of studies in collaboration with international consortia.
A newly released database containing 250 million protein analyses in neurodegenerative diseases presents exciting opportunities, and we are also collaborating with PRECISE, a major consortium based in Singapore.
In this seminar, Roger Chang from Standard BioTools will highlight how to access these public databases and approaches for analyzing proteomics data.
Participation fee: This event is sponsored by Umeå Biotech Incubator (UBI) with support from the European Union. There is no actual fee for participating. For delegates from the industry, state-aid/de-minimis will be accounted for corresponding to 50 SEK per person.
State aid & de-minimis: Umeå Biotech Incubator is obliged to account for activities they arrange, and support they provide, that are directed to specific companies or a group of companies where the receiving companies do not pay market price for the participation. The value of this support is accounted for as state-aid.
Small amounts of State aid (‘de minimis’ aid) are exempted from State aid control, as they are deemed to have no impact on competition and trade in the internal market of the European Union (EU). De minimis aid indeed refers to small amounts of State aid to undertakings (companies) that do not have to be notified to the European Commission by the EU Member States.
The maximum amount is € 300,000 for each undertaking over 3 years.
De minimis can also be granted to large companies that are not entitled to larger sums of state-aid under Article 22.
You are using an outdated browser. Please upgrade your browser to improve your experience.